Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892)
10/2009
10/27/2009US7608422 Gene therapy; vaccines; inducing antibodies and/or cytotoxic or helper T lymphocytes
10/27/2009US7608401 Mutations in the ferroportin 1 gene associated with hereditary haemochromatosis
10/27/2009US7608398 Minimally cross-hybridizing nucleotide sequences; provides of a family of molecules which is sufficiently large and where each individual member is sufficiently selective for its complement over all the other zipcode molecules
10/27/2009US7608397 Using variation in dielectric constant as tool in detecting change in conformational or energetic state of molecular species
10/27/2009US7608396 Systems, tools and methods of assaying biological materials using spatially-addressable arrays
10/27/2009US7608395 Predicts the likelihood of renal involvement, diagnose SLE, distinguish SLE gene expression profiles from profiles of patients infected with influenza, and to monitor disease progression and treatment
10/27/2009US7608393 Methods of predicting a benefit of antioxidant therapy for prevention of cardiovascular disease in hyperglycemic patients
10/27/2009US7608276 vaccines, immunogenic compositions; diagnostics, enzymatic studies and targets for antibiotics; for treating Staphylococcus aureus infection
10/27/2009US7608267 Fusion protein of two different cytokines, one capable of enhancing a nonspecific immune response, and the other capable of enhancing a specific immunity; fusion protein of Interleukin-2 (Il-2) and IL-7 for example; use in immunotherapy such as cancer vaccine
10/27/2009US7608263 RG1 antibodies and uses thereof
10/27/2009US7608256 Methods to increase transgene expression from bacterial-based delivery systems by co-expressing suppressors of the eukaryotic type I interferon response
10/27/2009CA2372085C L-ribo-lna analogues
10/27/2009CA2327547C Oligonucleotides containing pyrazolo[3,4-d]pyrimidines for hybridization and mismatch discrimination
10/27/2009CA2230967C Improved nucleic acid assays
10/27/2009CA2224143C Recombinant hexose oxidase, a method of producing same and use of such enzyme
10/22/2009WO2009129236A2 Method for manipulating samples with magnetic nucleation nanoparticles
10/22/2009WO2009128266A1 Sequence-specific nucleic acid purification method manner
10/22/2009WO2009127154A1 A newly identified human rhinovirus of hrv-c and methods and kits for detecting hrv-cs
10/22/2009WO2009127081A1 A newly identified human rhinovirus of hrv-c and methods and kits for detecting hrv-cs
10/22/2009WO2009127060A1 Novel lipid formulations for nucleic acid delivery
10/22/2009WO2009105572A3 Antisense modulation of amyloid beta protein expression
10/22/2009WO2009048873A4 Detection of atypical pneumonia
10/22/2009WO2007025085A8 Genemap of the human genes associated with crohn's disease
10/22/2009US20090265816 Isolated nucleic acid molecules from the genome of citrus leprosis virus and uses thereof
10/22/2009US20090265812 Plant Gene Promoter and its Use
10/22/2009US20090265809 Modified Cry3A Toxins and Nucleic Acid Sequences Coding Therefor
10/22/2009US20090265808 P15 hairpin constructs and use
10/22/2009US20090265806 Pericarp-preferred regulatory element
10/22/2009US20090265805 Glutamate receptors in nutrient sensing, metabolism, Growth and Development
10/22/2009US20090265796 DNA segment that confers increased episomal stability, persistence or abundance of the isolated DNA molecule in a host cell; genetic engineering
10/22/2009US20090265795 Methods of Inhibiting Multiple Cytochrome P450 Genes with siRNA
10/22/2009US20090264666 Delta-8 desaturase and its use in making polyunsaturated fatty acids
10/22/2009US20090264636 Conjugates and compositions for cellular delivery
10/22/2009US20090264635 Methods and compositions for depleting abundant rna transcripts
10/22/2009US20090264634 Sequences characteristic of hypoxia-regulated gene transcription
10/22/2009US20090264632 Device and a method for promoting crystallisation
10/22/2009US20090264616 Cyclodipeptide Synthetases and Their Use for Synthesis of Cyclo(Leu-Leu) Cyclodipeptide
10/22/2009US20090264512 exposing the sample to an aptamer that specifically binds a protein selected from Listeria monocytogenes internalin B protein and Listeria monocytogenes internalin A protein; for treating or preventing Listeria infection
10/22/2009US20090264511 Compositions and methods for inhibiting expression of factor vii gene
10/22/2009US20090264510 Double helical oligonucleotides interfering with mRNA used as effective anticancer agents
10/22/2009US20090264508 Focused Libraries, Functional Profiling, Laser Selex, and Deselex
10/22/2009US20090264507 Method of diagnosing gum disease-wound healing using single nucleotide polymorphism profiles
10/22/2009US20090264505 Methods and compositions for rnai mediated inhibition of gene expression in mammals
10/22/2009US20090264504 For modulating human immunodeficiency virus (HIV) gene expression ; nucleic acids with a pyrimidine modification; AIDS
10/22/2009US20090264503 Short interference ribonucleic acids for treating allergic diseases
10/22/2009US20090264502 Compositions and their uses directed to hsp27
10/22/2009US20090264501 Methods and Compositions to Inhibit P2x7 Receptor Expression
10/22/2009US20090264364 Genes implicated in the regulation of angiogenesis, pharmaceutical preparations containing them and their applications
10/22/2009US20090264361 Identification of a family of secreted proteins in vascular endothelium
10/22/2009US20090264358 Vegf receptor fusion proteins, their pharmaceutical compositions and therapeutic applications for the eye diseases
10/22/2009US20090264353 Splice Switching Oligomers for TNF Superfamily Receptors and their Use in Treatment of Disease
10/22/2009US20090264349 CD30 Ligand
10/22/2009US20090264344 cyclic polypeptide biodrug; NONHEMOLYTIC, MINIMAL IN VITRO CYTOTOXICITY; TREATMENT OF BACTERIAL, VIRAL INFECTION, ESPECIALLY ONE CAUSED BY HIV-1 RETROVIRUS OR OTHER SEXUALLY-TRANSMITTED PATHOGENS
10/22/2009US20090264311 Thermostable peroxide-driven cytochrome P450 oxygenase variants and methods of use
10/22/2009US20090264305 Polynucleotide Marker Genes and their Expression, for Diagnosis of Endotoxemia
10/22/2009US20090264304 Normalized nucleic acid libraries and methods of production thereof
10/22/2009US20090264300 Enzymatic encoding methods for efficient synthesis of large libraries
10/22/2009US20090263908 Liquid crystal condensation of nucleic acid (na) complexes
10/22/2009US20090263900 Linear donor constructs for targeted integration
10/22/2009US20090263888 Koji mold-origin phospholipase a2
10/22/2009US20090263886 Farnesyl dibenzodiazepinone and processes for its production
10/22/2009US20090263868 Nucleotide Compositions Comprising Photocleavable Markers And Methods Of Preparation Thereof
10/22/2009US20090263865 Substance Specific to Human PD-1
10/22/2009US20090263862 Novel alkane polyol dehydrogenase
10/22/2009US20090263847 Lsr receptor, its activity, its cloning and its applications to the diagnosis, prevention and/or treatment of obesity and related risks or complications
10/22/2009US20090263811 Target base discrimination method
10/22/2009US20090263797 Reversible di-nucleotide terminator sequencing
10/22/2009US20090263795 DIAGNOSTIC METHODS INVOLVING DETERMINING GENE COPY NUMBERS AND SNPs IN THE FcyRII/FcyRIII GENE CLUSTER, AND PROBES FOR USE IN SUCH METHODS TO DETECT SUSCEPTIBILITY TO AND TREATMENT EFFICACY IN AUTOIMMUNE DISEASES
10/22/2009US20090263791 Chemically Cleavable 3'-O-Allyl-DNTP-Allyl-Fluorophore Fluorescent Nucleotide Analogues and Related Methods
10/22/2009US20090263790 Methods for Identifying Functionally Related Genes and Drug Targets
10/22/2009US20090263447 Crosslinked hyaluronic acid and process for the preparation thereof
10/22/2009US20090263425 Methods of stimulating an immune response against prostate specific antigen
10/22/2009US20090263424 Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses
10/22/2009US20090263413 Immunostimulatory oligonucleotides and use thereof in pharmaceuticals
10/22/2009US20090263406 JY-1 Regulation Of Granulosa Cell Function And Early Embryonic Development In Cattle
10/22/2009US20090263405 CpG OLIGONUCLEOTIDE PRODRUGS, COMPOSITIONS THEREOF AND ASSOCIATED THERAPEUTIC METHODS
10/22/2009US20090263403 DNAX Accessory Protein, 12 kD (DAP12); useful in modulating development of cells such as lymphoid and myeloid; for modulating of immune responses; fusion proteins
10/22/2009US20090263402 Growth Differentiation Factor-11
10/22/2009US20090263395 Genes and polypeptides relating to breast cancers
10/22/2009US20090263394 A34 and a33-like 3 dna protein, antibodies thereto and methods of treatment using same
10/22/2009US20090263392 Methods of modifying antibodies for purification of bispecific antibodies
10/22/2009US20090263380 Anti-idiotypic antibodies neutralizing the inhibitory activity of an inhibitory antibody directed against the c1 domain of factor viii
10/22/2009US20090263379 Monoclonal antibodies for inhibition of laminin-8 expression to inhibit human gliomas
10/22/2009US20090263368 Genetic variations associated with psychiatric disorders
10/22/2009US20090263364 Method and constructs for delivering double stranded rna to pest organisms
10/22/2009US20090263354 Compositions and siRNAs for inhibiting C/EBPbeta
10/22/2009US20090263323 Novel means and methods for the treatment of hearing loss and phantom hearing
10/22/2009CA2721333A1 Novel lipid formulations for nucleic acid delivery
10/21/2009EP2110445A2 Molecular tagging system
10/21/2009EP2110379A2 Mammalian sphingosine kinase type 2 isoforms, and uses thereof
10/21/2009EP1689883B1 Methods and compositions for the preparation and use of fixed-treated cell-lines and tissue in fluorescence in situ hybridization
10/21/2009EP1654378B1 Methods for chemically synthesizing immunoglobulin chimeric proteins
10/21/2009EP1499885B1 Novel fusion proteins and assays for molecular binding
10/21/2009EP1117672B1 Antisense modulation of survivin expression
10/21/2009EP1047784B1 Neissera meningitidis antigens
10/21/2009CN101563356A A mortierella alpina C16/18 fatty acid elongase
10/21/2009CN101563104A Polypeptide-nucleic acid conjugate for immunoprophylaxis or immunotherapy for neoplastic or infectious disorders
10/21/2009CA2663302A1 Ribonucleotide tag nucleic acid detection
10/20/2009USRE40940 DNA sequences from the K. lactis PGK gene having transcriptional promoter activity; expression vectors comprising these sequences and to their use for the production of proteins
10/20/2009US7605316 Plants and seeds of hybrid corn variety CH820648
1 ... 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 ... 899